Analysis reveals UBE2T impacts nucleolar function in IDH1/TP53-mutant glioma, suggesting potential therapeutic targets.
Supplementary Figure S2: Supplementary data on glioma public databases and tissue samples.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: